| Value | ₹904.0 Cr |
|---|
NSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.
Windlas Biotech Ltd: key numbers
- Share price
- ₹881.10
- Market cap
- ₹1,849 Cr
- Revenue (annual)
- ₹904.1 Cr
- Net profit (annual)
- ₹66.44 Cr
- P/E (TTM)
- 27.8×Sector 48.7×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Windlas Biotech Ltd
All →Windlas Biotech Board Meeting Date
Windlas Biotech intimated that its Board meeting is scheduled for 5 November 2026 to consider unaudited standalone results for Q1 FY27. No monetary figure is disclosed in this advance notice.
Windlas Biotech Other Announcement
This quarterly shareholding pattern statement for Windlas Biotech Ltd, covering the period ended September 30, 2026, provides the company's equity ownership breakdown.
Windlas Biotech Management Change
Windlas Biotech appointed Aashish Mehra and Soni Saran Singh as Independent Directors. Vivek Dhariwal resigned as Independent Director and Chairman of the Board.
Windlas Biotech Earnings Call Transcript: Key Takeaways
Windlas Biotech reported record quarterly revenue driven by 29% growth in CDMO vertical. Management focuses on operational excellence and capacity expansion via Plant 6 commercialization.
Windlas Biotech Results Update
Windlas Biotech reported Q1 FY27 revenue of Rs 248 crore, an 18% YoY growth. The release highlights an adjusted EBITDA of Rs 34 crore and PAT of Rs 25 crore.
Windlas Biotech Investor Presentation: Key Takeaways
Windlas Biotech reported Q1FY27 revenue of ₹248 Cr (18% YoY). Adjusted EBITDA and PAT grew 26% and 37% respectively, excluding ESOP costs, driven by CDMO expansion.
Other results update announcements
All →Msafe Equipments Results Update
Msafe Equipments reported 54% revenue growth and 55% PAT growth in Q2FY27. Rental share rose to 52% as warehouse network expanded from 21 to 24.
- MS scaffolding manufacturing capacity
- 15000.0 tons
Pune E-Stock Broking Results Update
Pune E-Stock Broking reported H1FY27 revenue of ₹43.8 Cr and PAT of ₹14.3 Cr. EBITDA rose 31% YoY to ₹22.3 Cr on stronger broking and MTF volumes.
Sportking India Results Update
Sportking India reported Q2 FY27 revenue of ₹781.1 Cr with PAT up 240.9% YoY. H1 PAT reached ₹172.3 Cr on strong textile demand.
- textile spindle capacity
- 150000 spindles
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Hi-Green Carbon Results Update
Hi-Green Carbon reported H1 FY27 highlights. Consolidated revenue rose 40.9% to ₹99.78 Cr with PAT of ₹6.69 Cr.
Srivasavi Adhesive Tapes Results Update
Srivasavi Adhesive Tapes reported H1 FY27 revenue of ₹73.20 Cr, up 39% YoY, and PAT of ₹3.80 Cr. FY27 sales are expected to significantly exceed FY26.